Nova Biomedical develops, manufactures, and sells advanced technology blood testing analyzers. We employ over 1,400 people, with sales and service subsidiaries in ten (10) countries and distributors in more than 100 additional countries. Nova has manufacturing facilities in Waltham and Billerica, Massachusetts; and Taipei, Taiwan. Nova is one of the 25 largest in vitro diagnostic companies in the world and the largest privately owned in vitro diagnostic company in the United States.
Worldwide Market Areas Include:
Hospital Blood Gas and Critical Care Analyzers
Nova Biomedical is the world technology leader in the development of fast, whole blood analyzers to support the care of hospitalized and critically ill patients. Nova analyzers offer the most extensive stat test menus and deliver results in the shortest time at the lowest costs. Nova also provides handheld meter-and-strip based measuring systems for glucose, ketone, lactate, and creatinine point-of-care testing. Whether testing is performed in the central laboratory or in emergency, surgical, critical, or respiratory care areas, Nova analyzers can help to improve patient outcomes while reducing the cost of care.
Clinic / Doctor's Office, Blood Bank, Pre-Hospital / Ambulance, Veterinary and Sports Medicine
Measurements in these markets include HbA1c, Lipids, UACR, PT/INR, CRP, Glucose, Ketone, Lactate and Hb / Hct
Chemistry and Cell Culture Analyzers for Biotechnology
Nova manufactures a series of BioProfile® automated cell culture analyzers for rapid analysis of key nutrients, metabolites, pH, gases, and cell density/cell viability.
Self-Testing Diabetes Meters
Nova develops and manufactures blood glucose meters and test strips for self-testing by patients with diabetes. The glucose meters are distributed under the Nova Max® label in the U.S. and Canada, the Menarini label in Europe and the Walgreen's label in the U.S.
Product Development and Manufacturing for Corporate Partners
In addition to Nova products, we develop and manufacture medical devices and diagnostic products for many of the world’s leading healthcare corporations.
Pioneering Technological Innovations
Nova Biomedical has a 40-year history as the world leader in developing whole blood biosensors for clinical and cell culture/fermentation use.
A Global Company
Nova has sales and service operations in 110 countries through Nova subsidiaries or distributors. Nova’s wholly-owned subsidiaries are located in Benelux, Brazil, Canada, France, Germany, Italy, Japan, Spain, Switzerland, UK and the US, with distributors in 100 additional countries. Nova subsidiaries and distributors provide product information, demonstrations, local product inventory, and complete technical support. Whether you are located in North America, Europe, Russia, Eastern Europe, the Middle East, Africa, Asia, the Pacific Islands, Latin America, or the Indian Subcontinent, Nova can support your point-of-care and critical care testing needs. Nova’s global manufacturing operations take place in four facilities certified by the International Organization for Standardization (ISO) and are located in Waltham and Billerica, Massachusetts, USA and Taipei, Taiwan. These facilities occupy a total of 420,000 square feet (42,000 square meters) of manufacturing space.
Canada operates with the domestic head office and warehouse in Mississauga, ON and additional warehouses located in British Columbia and Ontario.
Measurement Technologies Used by Nova Analyzers
Potentiometric (whole blood or plasma), Amperometric (whole blood/plasma or cell culture media), Conductivity (whole blood), Immunochemistry (whole blood or plasma), Spectrophotometric (plasma and cell culture media), Photometric (lysed whole blood), Ellipsometry (saliva/urine), and Imaging (cell culture)
For more information about Nova Biomedical, please visit: www.novabiomedical.ca